Discovery Labs Rockets (DSCO)

Posted in pre-market 
September 11th, 2009

Discovery Laboratories Inc. (NASDAQ: DSCO) is rocketing higher by 50% to a whole high price of $0.74 on 1 million shares as of 8:36 AM EST… Average volume is 3.5 million shares and the 52-week high is $2.40.  The FDA has set a review date of September 29 for the lung drug SURFAXIN.  The market cap even after the run here is only about $80 million. As a reminder, this one lost half of its value in April and then again in late June or Early July.  -JON OGG

Comments are closed